Latest News & Updates
Breaking News
10 minutes ago
Simantini Singh Deo
Other trending news you may like to read
Rectify Pharmaceuticals Appoints Constantine Chinoporos As Executive Chairman To Lead Next Phase Of Growth
Rectify Pharmaceuticals names Constantine Chinoporos Executive Chairman as RTY-406 enters Phase 1 trials.
Simantini Singh Deo
NewcelX Secures Brazilian Patent For NCEL-101 Manufacturing Technology Ahead Of Clinical Development
NewcelX secures Brazilian patent for NCEL-101's manufacturing tech, advancing its type 1 diabetes stem cell therapy.
Simantini Singh Deo
Attovia Therapeutics Appoints Biotech Finance Leader John Smither To Its Board Of Directors
Attovia Therapeutics appoints John Smither to its Board as independent director and Audit Committee Chair.
Simantini Singh Deo
Mesoblast Reaches Key Milestone in Phase 3 Trial of Rexlemestrocel-L for Chronic Back Pain
Mesoblast hits 300-patient enrollment target in its Phase 3 MSB-DR004 trial of rexlemestrocel-L for chronic low back pain, with top-line results and BLA submission targeted for mid-2027.
Simantini Singh Deo
